| Literature DB >> 34520110 |
Puguang Xie1,2, Yuyao Li1,2, Bo Deng1, Chenzhen Du1,2, Shunli Rui1, Wu Deng3, Min Wang1,2, Johnson Boey4, David G Armstrong5, Yu Ma1,2, Wuquan Deng1,2.
Abstract
Diabetic foot ulcer (DFU) is one of the most serious and alarming diabetic complications, which often leads to high amputation rates in diabetic patients. Machine learning is a part of the field of artificial intelligence, which can automatically learn models from data and better inform clinical decision-making. We aimed to develop an accurate and explainable prediction model to estimate the risk of in-hospital amputation in patients with DFU. A total of 618 hospitalised patients with DFU were included in this study. The patients were divided into non-amputation, minor amputation or major amputation group. Light Gradient Boosting Machine (LightGBM) and 5-fold cross-validation tools were used to construct a multi-class classification model to predict the three outcomes of interest. In addition, we used the SHapley Additive exPlanations (SHAP) algorithm to interpret the predictions of the model. Our area under the receiver-operating-characteristic curve (AUC) demonstrated a 0.90, 0.85 and 0.86 predictive ability for non-amputation, minor amputation and major amputation outcomes, respectively. Taken together, our data demonstrated that the developed explainable machine learning model provided accurate estimates of the amputation rate in patients with DFU during hospitalisation. Besides, the model could inform individualised analyses of the patients' risk factors.Entities:
Keywords: amputation; diabetic foot; forecasting; machine learning; precision medicine
Mesh:
Year: 2021 PMID: 34520110 PMCID: PMC9013600 DOI: 10.1111/iwj.13691
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.099
Baseline characteristics of patients by clinical outcomes
| Variables | Non‐amputation (n = 500) | Minor amputation (n = 71) | Major amputation (n = 47) |
|
|---|---|---|---|---|
| Demographic data | ||||
| Age, years | 66.0 ± 12.3 | 68.1 ± 10.4 | 66.4 ± 12.7 | .843 |
| Sex | .327 | |||
| Male, % | 62.6 | 60.6 | 55.3 | |
| Female, % | 37.4 | 39.4 | 44.7 | |
| Body mass index, kg/m2 | 24.2 ± 7.8 | 22.5 ± 3.4 | 22.8 ± 3.4 |
|
| Diabetes duration, years | 9.71 ± 7.51 | 10.8 ± 10.2 | 6.98 ± 6.24#▲ | .185 |
| Smoking history, pack‐years | 15.2 ± 28.7 | 12.9 ± 23.7 | 13.3 ± 31.7 | .591 |
| Pre‐hospital delay, days | 47.1 ± 81.2 | 53.9 ± 103.9 | 73.8 ± 95.9# |
|
| Medical history | ||||
| Hypertension, % | 56.0 | 66.2 | 42.6▲ | .438 |
| Coronary heart disease, % | 24.8 | 32.4 | 17.0 | .708 |
| Heart failure, % | 18.0 | 23.9 | 14.9 | .921 |
| Cerebral infarction, % | 15.6 | 18.3 | 10.6 | .621 |
| Diabetic neuropathy, % | 75.4 | 64.8 | 66.0 |
|
| Diabetic retinopathy, % | 32.2 | 26.8 | 23.4 | .140 |
| Diabetic nephropathy, % | 45.2 | 47.9 | 31.9 | .196 |
| Peripheral vascular disease, % | 36.4 | 42.3 | 36.2 | .687 |
| Arterial occlusion, % | 16.2 | 25.4 | 6.4▲ | .553 |
| Gangrene, % | 16.0 | 73.2 | 72.3# |
|
| Prior DFU, % | 24.8 | 29.6 | 25.5 | .629 |
| Prior amputation, % | 4.8 | 9.9 | 10.6 |
|
| Clinical and laboratory data | ||||
| HbA1c, % | 8.65 ± 3.92 | 9.28 ± 4.94 | 9.61 ± 4.29 | .086 |
| HbA1c, mmol/mol | 71.0 ± 32.2 | 78.0 ± 41.5 | 82.0 ± 36.6 | .086 |
| Random blood glucose, mmol/L | 14.6 ± 8.5 | 16.3 ± 7.3 | 16.2 ± 7.8 | .082 |
| White blood cell, g/L | 8.08 ± 4.27 | 10.3 ± 5.1 | 12.4 ± 5.4#▲ |
|
| Percentage of neutrophils, % | 68.9 ± 13.0 | 75.0 ± 10.8 | 78.3 ± 9.4# |
|
| Haemoglobin, g/L | 116.0 ± 21.3 | 106.1 ± 22.0 | 98.7 ± 20.8# |
|
| Serum potassium, mmol/L | 4.06 ± 0.81 | 3.85 ± 0.50 | 3.92 ± 0.88 |
|
| Serum sodium, mmol/L | 138.7 ± 8.9 | 137.1 ± 4.7 | 136.5 ± 4.8# |
|
| Serum creatinine, μmol/L | 110.3 ± 114.2 | 107.1 ± 119.2 | 115.7 ± 180.8#▲ | .283 |
| Serum albumin, g/L | 35.4 ± 6.8 | 33.1 ± 5.8 | 29.6 ± 6.1#▲ |
|
| Total cholesterol, mmol/L | 4.27 ± 1.18 | 4.25 ± 1.22 | 3.69 ± 1.18#▲ | .126 |
| Triglyceride, mmol/L | 1.67 ± 1.25 | 1.59 ± 0.74 | 1.40 ± 0.58 | .879 |
| LDL‐C, mmol/L | 2.47 ± 0.84 | 2.46 ± 0.93 | 2.14 ± 0.82# | .137 |
| HDL‐C, mmol/L | 1.07 ± 0.45 | 1.00 ± 0.31 | 0.84 ± 0.30#▲ |
|
| Medication history | ||||
| Antihyperglycemic drugs use | 45.2 | 49.3 | 21.3#▲ |
|
| Insulin use | 45.8 | 35.2 | 34.0 | .056 |
| Classification systems | ||||
| Wagner classification system |
| |||
| 0‐3, % | 90.6 | 35.2 | 23.4# | |
| 4‐5, % | 9.4 | 64.8 | 76.6# | |
| WIfI classification system | ||||
| Wound |
| |||
| 0‐2, % | 94.8 | 78.9 | 61.7#▲ | |
| 3, % | 5.2 | 21.1 | 38.3#▲ | |
| Ischaemia, % | 59.8 | 78.9 | 83.0# |
|
| Foot infection |
| |||
| 0‐2, % | 96.6 | 88.7 | 83.0# | |
| 3, % | 3.4 | 11.3 | 17.0# | |
Note: P values in the table were the results of the trend test between the three groups. P value < .05 was considered statistically significant. Bold values indicated significant trend toward increasing or decreasing between no amputation group, minor amputation group, and major amputation group.
Abbreviations: DFU, diabetic foot ulcer; HbA1c, haemoglobin A1c; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol.
Indicated significant difference between no amputation group and minor amputation group; # indicated significant difference between no amputation group and major amputation group; ▲ means significant difference between minor amputation group and major amputation group, respectively.
FIGURE 1Discrimination and calibration performance of the multi‐class classification model. (A) Receiver‐operating‐characteristic curves (ROC) for each class and their weighted average ROC curve. (B) Calibration curves for each class of the model
The values of the evaluation metrics of the multi‐class classification model in the test set
| Evaluation metrics | Non‐amputation | Minor amputation | Major amputation | Overall |
|---|---|---|---|---|
| Sensitivity | 95.0% | 64.3% | 33.3% | 87.1% |
| Specificity | 69.6% | 94.5% | 97.3% | 74.4% |
| NPV | 76.2% | 95.4% | 94.9% | 79.7% |
| PPV | 93.2% | 60.0% | 50.0% | 86.3% |
Abbreviations: NPV, negative predictive value; PPV, positive predictive value.
FIGURE 2Illustrative example of SHAP algorithm for interpreting the developed model. Illustrative example of how baseline risk and patient characteristics constitute the risk of non‐amputation, minor amputation and major amputation predicted by the model. The baseline risk was obtained by calculating the average value of the prediction of the model in the training set samples